Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Impact of Time-In-Range on Diabetes Management

How does Dupixent help recover smell?

New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

ADA/EASD recommend considering combination injectables therapy of basal insulin/GLP-1 RA (Such as Soliqua®) as valuable treatment option to provide adequate efficacy for achieving and maintaining glycemic goals.

Inspiring Stories of Patients Living with ASMD

What can biologic treatment do for patients with CRS with nasal polyps?

Their Stories shaped them like Pearls

How To Diagnose LSDs?

Learn more about early diagnosis of lysosomal storage disorders: Fabry disease, Pompe Disease, Gaucher disease, Acid Sphingomyelinase Deficiency (ASMD, also known as Niemann-Pick Type A/B), mucopolysaccharidoses (MPSs).

Better care for Fabry

Post-exercise hypoglycemia in relation to medication regimen among adults with type 2 diabetes

What Is Time-in-Range?

ASMD Phenotypes

Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control